Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
TTR Therapies Show Delayed Mortality Benefit in ATTR-CM
Added: 2 months ago Source:  Radcliffe Cardiology
Therapies for transthyretin amyloidosis with cardiomyopathy (ATTR-CM), including transthyretin (TTR) stabilisers and silencers, have demonstrated a mortality benefit in randomised trials. However, the timing of this benefit has been a subject of debate. A new analysis of three major outcomes trials has evaluated this time course, revealing a consistent pattern across different treatments… View more

Heart Failure
AHA 2025 Highlights: New Insights on Icosapent Ethyl
Author(s): Deepak L Bhatt , Payal Kohli Added: 4 months ago
Filmed onsite at the AHA 2025 congress, leading specialists Dr Payal Kohli and Dr Deepak Bhatt explore the evolving landscape of triglyceride-lowering therapy in cardiovascular disease.They review new REDUCE-IT sub-analysis data on icosapent ethyl efficacy by aspirin use, examine updated ESC guideline recommendations and discuss how eicosapentaenoic acid (EPA) delivers cardioprotective benefits… View more

Heart Failure

Prevention & Chronic Conditions
Transthyretin Cardiac Amyloidosis: A Right-atrial Variant
Author(s): Narra Lavanya , Abraham Oomman Added: 1 year ago

Imaging & Diagnostics

Heart Failure
Author(s): Julian Gillmore , Margot K Davis , Ahmad Masri , et al Added: 1 year ago
First presented at ESC 2024, this on-demand programme sees Prof Julian Gillmore (University College London, London, UK) lead a distinguished faculty compromising of Dr Ahmad Masri (Oregon Health & Science University Medical Group, Portland, US), Dr Margot Davis (University of British Columbia, Vancouver, CA), and Dr Giuseppe Vergaro (Sant’Anna, Pisa, IT).The faculty present recent epidemiological… View more

Heart Failure
COVID-19 and Cardiovascular Care in Asia-Pacific
Author(s): Mitsuaki Sawano , Misato Chimura , Jonathan Yap , et al Added: 1 year ago

Imaging & Diagnostics

Prevention & Chronic Conditions
Cardiac Amyloidosis: Everywhere, but Nowhere
Author(s): Aqtab Mazhar Alias , Raja Ezman Raja Shariff , Norashikin Saidon , et al Added: 2 years ago

Heart Failure
Diagnostic Red Flags are Common in Hypertrophic Cardiomyopathy, Study Finds
Added: 7 months ago Source:  Radcliffe Cardiology
According to European Society of Cardiology (ESC) guidelines, a systematic search for diagnostic clues, or ‘red flags’ (RFs), is recommended in patients with hypertrophic cardiomyopathy (HCM) to help tailor disease management. A new study published in the European Heart Journal has investigated the prevalence and clinical significance of these RFs across different HCM phenotypes and clinical… View more

Imaging & Diagnostics

Inherited and Congenital Cardiac Conditions
Setting-up an HCM Clinic
Added: 1 year ago
In the first episode, Prof Juan Pablo Kaski and Prof Ruxandra Jurcut discuss the essentials of establishing an HCM Clinic, covering its objectives, logistical aspects, systemic challenges, and operational strategies, including referral practices and collaboration with specialist centres. View more

Heart Failure
Ep 143: GDMT Optimisation: Mitigating SCD Risk and Addressing Women’s Cardiac Health
Added: 6 months ago
In this episode of Parallax, Dr Ankur Kalra speaks with Dr Benjamin A D’Souza, Associate Professor of Medicine at the University of Pennsylvania and Section Chief of Cardiac Electrophysiology at Presbyterian Medical Center. Together, they explore the challenges of mitigating sudden cardiac death and the evolving role of guideline-directed medical therapy in optimising patient outcomes.Dr D’Souza… View more

Heart Failure
Low-Dose Triple Pill vs Monotherapy for Hypertension
Added: 1 month ago Source:  Cardiac Failure Review
Single-pill low-dose combination (LDC) therapy is an emerging strategy for improving blood pressure (BP) control in patients with hypertension.¹ Two new phase III trials, HM-APOLLO-301 and HM-APOLLO-302, have evaluated the efficacy and safety of an ultra-low-dose triple combination pill compared with standard-dose monotherapy as an initial treatment for mild-to-moderate hypertension… View more

Prevention & Chronic Conditions

Cardiovascular Renal Metabolic